All GLG News Analyses Filed Under: Legal Issues

Microsoft's recent settlement of its patent dispute with Visto obviously had implications for those two firms; but the settlement also hurt RIMM in its attempt to make Visto cut a deal.

Investors in IDCC have long worried that, even if the firm has good patents, it will be years until Nokia and Samsung pay their first penny.  That is why this week's news about intense settlement negotiations caused a stock spike.  But it is also why InterDigital has to be cautious when it...

The current subprime problems will likely affirm the need for things like Sarbanes-Okley & Corporate Governance? While the US has certainly developed a reputation for being litigious, holding some accountable for the fall out on the subprime issues should not be limped in this category!...

If the Rode Island Lead Paint ruling is upheld 3 companies face billions in exposure! Was this another case in which the jury heard just a little to much possible wrongdoing & skipped Proximate Cause right to send a message?

(1) The US Court of Appeals for the Federal Circuit - in a complicated 22-page split Opinion earlier today Wed 19 Mar 2008 - provided Amgen another victory in its long patent battle(s) with Hoffmann-LaRoche. (2) Amgen's Aranesp® and EPOGEN® (each a prescription only product...

Under the current administration, the FDA has tried to use drug approval as a shield.  In some cases, the current court has held warning approval to bar lawsuits.  However, this can be remedied by Congress explicitly clarifying that the FDA approval of a drug does not preempt state law....

The importance of this ruling lies not so much in its possible implications for the future of Iberdrola, but what it means for the EU Energy Market? Its a clear message to France, Germany and Italy and their monopolized energy markets and its one step closer to Brussels objective...

Investors, including bankcard issuers, want the Visa IPO to be at least as successful as MasterCard's in '06. Visa's global legal problems, which are especially acute in the US and EU, could burden Visa far into the future. The US credit crunch could hold surprises for Visa, more so if Democrats...

Nokia has just won a ruling against Qualcomm. A disaster for technology valuation and patent setting.

Does FDA approval provide a cloak for certain types of lawsuits? Should State laws be allowed to in essence carve out exceptions to what appears to be Federal regulation?